Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study.
Bigseth TT, Fredriksen M, Egeland J, Andersen E, Andreassen OA, Bang-Kittilsen G, Falk RS, Holmen TL, Martinsen EW, Mordal J, Nielsen J, Steen NE, Ueland T, Vang T, Engh JA.
Bigseth TT, et al. Among authors: vang t.
Schizophr Res. 2021 Feb;228:190-192. doi: 10.1016/j.schres.2020.11.051. Epub 2021 Jan 13.
Schizophr Res. 2021.
PMID: 33450603
No abstract available.